Literature DB >> 17328733

Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.

L-C Kuo1, C-C Lai1, C-H Liao1, C-K Hsu1, Y-L Chang1, C-Y Chang1, P-R Hsueh2.   

Abstract

Nosocomial infections caused by Acinetobacter baumannii have increased in recent years. Isolates of multidrug-resistant A. baumannii (MDRAB) have been recovered in Taiwan since 1999. The characteristics of 55 patients with MDRAB bacteraemia infections occurring between January 2003 and February 2005 were analysed retrospectively. The overall 30-day mortality rate was 49%. The portal of entry was identified in 80% of patients, with the respiratory tract being implicated most frequently. Among the different antimicrobial regimens prescribed, the combination of a carbapenem and ampicillin-sulbactam was associated with a better outcome than the combination of a carbapenem and amikacin, or a carbapenem alone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328733     DOI: 10.1111/j.1469-0691.2006.01601.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  38 in total

Review 1.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

2.  Hidden VIM-1 metallo-beta-lactamase phenotypes among Acinetobacter baumannii clinical isolates.

Authors:  Alexandros Ikonomidis; Eleni Ntokou; Antonios N Maniatis; Athanassios Tsakris; Spyros Pournaras
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

Review 3.  Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review.

Authors:  P Poulikakos; G S Tansarli; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-16       Impact factor: 3.267

4.  Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology.

Authors:  Ming-Hsien Chiang; Wang-Chou Sung; Shu-Pei Lien; Ying-Zih Chen; Annie Fei-yun Lo; Jui-Hsin Huang; Shu-Chen Kuo; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection.

Authors:  Greg Harris; Bruce E Holbein; Hongyan Zhou; H Howard Xu; Wangxue Chen
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 6.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

7.  A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.

Authors:  Greg Harris; Rhonda Kuo Lee; Christopher K Lam; Gregory Kanzaki; Girishchandra B Patel; H Howard Xu; Wangxue Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

8.  Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities.

Authors:  Yu-Chi Lin; Wang-Huei Sheng; Shan-Chwen Chang; Jann-Tay Wang; Yee-Chun Chen; Ruei-Jiuan Wu; Ko-Chiang Hsia; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

9.  Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice.

Authors:  Hongyu Qiu; Rhonda Kuolee; Greg Harris; Wangxue Chen
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

10.  The bioactivity of plant extracts against representative bacterial pathogens of the lower respiratory tract.

Authors:  Virgilio Bocanegra-García; María Del Rayo Camacho-Corona; Mónica Ramírez-Cabrera; Gildardo Rivera; Elvira Garza-González
Journal:  BMC Res Notes       Date:  2009-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.